TY - JOUR
T1 - Treatment of essential thrombocythemia with anagrelide
AU - Chintagumpala, Murali M.
AU - Kennedy, Laura L.
AU - Steuber, C. Philip
PY - 1995/9
Y1 - 1995/9
N2 - Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by persistent elevation in platelet count. It is a rare disorder in children, and children who have symptoms require treatment. We report the successful use of anagrelide, with few toxic effects, in the treatment of three children with ET. (J PEDIATR 1995; 127:495-8).
AB - Essential thrombocythemia (ET) is a myeloproliferative disorder characterized by persistent elevation in platelet count. It is a rare disorder in children, and children who have symptoms require treatment. We report the successful use of anagrelide, with few toxic effects, in the treatment of three children with ET. (J PEDIATR 1995; 127:495-8).
UR - http://www.scopus.com/inward/record.url?scp=0029164366&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0029164366&partnerID=8YFLogxK
U2 - 10.1016/S0022-3476(95)70090-0
DO - 10.1016/S0022-3476(95)70090-0
M3 - Article
C2 - 7658287
AN - SCOPUS:0029164366
SN - 0022-3476
VL - 127
SP - 495
EP - 498
JO - The Journal of Pediatrics
JF - The Journal of Pediatrics
IS - 3
ER -